Title:
CRYSTAL FORM OF 3,4-DIHYDROTHIENO[3,2-D]PYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2019/154192
Kind Code:
A1
Abstract:
A crystal form A of a 3,4-dihydrothieno[3,2-d]pyrimidine compound (1), a preparation method therefor and an application thereof in the preparation of an anti-human cytomegalovirus (HCMV) drug.
Inventors:
XIONG JIAN (CN)
WANG JINGJING (CN)
HU BOYU (CN)
TAN HAIZHONG (CN)
CHEN KEVIN X (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
WANG JINGJING (CN)
HU BOYU (CN)
TAN HAIZHONG (CN)
CHEN KEVIN X (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2019/073700
Publication Date:
August 15, 2019
Filing Date:
January 29, 2019
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
A61K31/519; C07D495/04; A61P31/22
Domestic Patent References:
| WO2016109360A1 | 2016-07-07 | |||
| WO2018028556A1 | 2018-02-15 |
Foreign References:
| CN1980925A | 2007-06-13 | |||
| CN1784390A | 2006-06-07 |
Other References:
See also references of EP 3753942A4
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: TECHNIQUES OF TRANSMITTING OVERLAPPING UPLINK CHANNELS
Next Patent: METHOD, APPARATUS AND SYSTEM FOR CONFIGURING REFERENCE SIGNAL
Next Patent: METHOD, APPARATUS AND SYSTEM FOR CONFIGURING REFERENCE SIGNAL